These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins. Raux B; Voitovich Y; Derviaux C; Lugari A; Rebuffet E; Milhas S; Priet S; Roux T; Trinquet E; Guillemot JC; Knapp S; Brunel JM; Fedorov AY; Collette Y; Roche P; Betzi S; Combes S; Morelli X J Med Chem; 2016 Feb; 59(4):1634-41. PubMed ID: 26735842 [TBL] [Abstract][Full Text] [Related]
30. BET Bromodomain as a Target of Epigenetic Therapy. Noguchi-Yachide T Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788 [TBL] [Abstract][Full Text] [Related]
31. The BD2 domain of BRD4 is a determinant in EndoMT and vein graft neointima formation. Zhang M; Wang B; Urabe G; Huang Y; Plutzky J; Kent KC; Guo LW Cell Signal; 2019 Sep; 61():20-29. PubMed ID: 31075399 [TBL] [Abstract][Full Text] [Related]
32. [Advances of structure and mechanisms of bromodomain-containing protein 4 and its related research in tumors]. Huang Q; Ding Y; Tan Y; Mo W; Li T; Huang Y; Hao W Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):132-148. PubMed ID: 36738206 [TBL] [Abstract][Full Text] [Related]
33. Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains. Zhang G; Plotnikov AN; Rusinova E; Shen T; Morohashi K; Joshua J; Zeng L; Mujtaba S; Ohlmeyer M; Zhou MM J Med Chem; 2013 Nov; 56(22):9251-64. PubMed ID: 24144283 [TBL] [Abstract][Full Text] [Related]
34. Nuclear magnetic resonance solution structure of the human Hsp40 (HDJ-1) J-domain. Qian YQ; Patel D; Hartl FU; McColl DJ J Mol Biol; 1996 Jul; 260(2):224-35. PubMed ID: 8764402 [TBL] [Abstract][Full Text] [Related]
35. Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors. Ember SW; Zhu JY; Olesen SH; Martin MP; Becker A; Berndt N; Georg GI; Schönbrunn E ACS Chem Biol; 2014 May; 9(5):1160-71. PubMed ID: 24568369 [TBL] [Abstract][Full Text] [Related]
36. BRD4 is a newly characterized transcriptional regulator that represses autophagy and lysosomal function. Wen X; Klionsky DJ Autophagy; 2017; 13(11):1801-1803. PubMed ID: 28837371 [TBL] [Abstract][Full Text] [Related]
37. Structure of the FHA1 domain of yeast Rad53 and identification of binding sites for both FHA1 and its target protein Rad9. Liao H; Yuan C; Su MI; Yongkiettrakul S; Qin D; Li H; Byeon IJ; Pei D; Tsai MD J Mol Biol; 2000 Dec; 304(5):941-51. PubMed ID: 11124038 [TBL] [Abstract][Full Text] [Related]
38. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails. Shen W; Xu C; Huang W; Zhang J; Carlson JE; Tu X; Wu J; Shi Y Biochemistry; 2007 Feb; 46(8):2100-10. PubMed ID: 17274598 [TBL] [Abstract][Full Text] [Related]
39. NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. Shen C; Ipsaro JJ; Shi J; Milazzo JP; Wang E; Roe JS; Suzuki Y; Pappin DJ; Joshua-Tor L; Vakoc CR Mol Cell; 2015 Dec; 60(6):847-59. PubMed ID: 26626481 [TBL] [Abstract][Full Text] [Related]
40. You bet-cha: a novel family of transcriptional regulators. Florence B; Faller DV Front Biosci; 2001 Aug; 6():D1008-18. PubMed ID: 11487468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]